Skip to main content
Login
Contact
Subscribe
Search form
Search
Custer County Chief
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
Callaway, NE
Chamber of Commerce
Community of Arnold
Custer County Courthouse
Custer County Foundation
Custer Economic Development Corp.
Police Department
Arcadia Schools
Arnold Schools
Broken Bow Schools
Callaway Schools
City of Broken Bow
Loup Schools
Mullen Schools
Sandhill Schools
Sargent Schools
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Denali Therapeutics Inc
(NQ:
DNLI
)
24.31
USD
+0.89 (+3.80%)
Streaming Delayed Price
/ Updated:
1:29 PM EDT, Aug 3, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
139,187
Open
23.71
Bid (Size)
24.32 (1)
Ask (Size)
24.34 (1)
Prev. Close
23.42
Today's Range
23.63 - 24.36
52wk Range
12.39 - 30.41
Shares Outstanding
94,441,892
Dividend Yield
N/A
Performance
YTD
+48.32%
+48.32%
1 Month
-4.67%
-4.67%
3 Month
+4.74%
+4.74%
6 Month
+6.95%
+6.95%
1 Year
+29.65%
+29.65%
Top News
More News
Denali Therapeutics Announces Phase 1b Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in COVID-19 Patients
July 29, 2020
from
GlobeNewswire News Releases
Flagship Pioneering Expands Executive Team with Appointment of Guillaume Pfefer as CEO-Partner
July 16, 2020
Flagship Pioneering, a unique life sciences innovation enterprise, today announced that it has further strengthened its executive leadership team with the appointment of life sciences industry veteran...
Read More
from
PR Newswire
More News
Read More
Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing
July 07, 2020
from
PR Newswire
Denali Therapeutics Provides Broad Update on Its RIPK1 Program Partnered With Sanofi
June 09, 2020
from
GlobeNewswire News Releases
Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity
May 28, 2020
from
PR Newswire
Denali Therapeutics Announces Publication of Two New Papers Describing Its Blood-Brain Barrier Delivery Technology in Science Translational Medicine
May 27, 2020
from
GlobeNewswire News Releases
Denali Therapeutics Reports First Quarter 2020 Financial Results and Provides COVID-19 Response Update
May 07, 2020
from
GlobeNewswire News Releases
Denali Therapeutics Provides Pipeline and Business Update in Response to the COVID-19 Pandemic
April 02, 2020
from
GlobeNewswire News Releases
Flagship Pioneering Completes Raising a New $1.1 Billion Capital Pool
April 02, 2020
from
PR Newswire
Denali Therapeutics Larger Than S&P 500 Component Nordstrom
June 24, 2020
category
Stocks
from
Market News Video
Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund
March 25, 2020
from
Business Wire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
